BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15862939)

  • 21. The role of food intolerance in irritable bowel syndrome.
    Lea R; Whorwell PJ
    Gastroenterol Clin North Am; 2005 Jun; 34(2):247-55. PubMed ID: 15862933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.
    Parkes GC; Brostoff J; Whelan K; Sanderson JD
    Am J Gastroenterol; 2008 Jun; 103(6):1557-67. PubMed ID: 18513268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postinfectious irritable bowel syndrome.
    DuPont AW
    Clin Infect Dis; 2008 Feb; 46(4):594-9. PubMed ID: 18205536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics in functional gastrointestinal disorders: what are the facts?
    Quigley EM
    Curr Opin Pharmacol; 2008 Dec; 8(6):704-8. PubMed ID: 18775516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
    Smith GD
    J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection, inflammation, and the irritable bowel syndrome.
    Spiller R; Garsed K
    Dig Liver Dis; 2009 Dec; 41(12):844-9. PubMed ID: 19716778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Irritable bowel syndrome: the challenge to psychosomatic and internal medical specialists to collaborate closely].
    Gündel H; Storr M
    MMW Fortschr Med; 2004 Jul; 146(29-30):24, 26-8. PubMed ID: 15540555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammation and microflora.
    Pimentel M; Chang C
    Gastroenterol Clin North Am; 2011 Mar; 40(1):69-85. PubMed ID: 21333901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Nutritional factors and nutritional therapy for irritable bowel syndrome--what is worthwhile?].
    Wächtershäuser A; Stein JM
    Z Gastroenterol; 2008 Mar; 46(3):279-91. PubMed ID: 18322884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychodynamic interpersonal therapy and improvement in interpersonal difficulties in people with severe irritable bowel syndrome.
    Hyphantis T; Guthrie E; Tomenson B; Creed F
    Pain; 2009 Sep; 145(1-2):196-203. PubMed ID: 19643544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Food: the forgotten factor in the irritable bowel syndrome.
    Eswaran S; Tack J; Chey WD
    Gastroenterol Clin North Am; 2011 Mar; 40(1):141-62. PubMed ID: 21333905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatments targeting putative mechanisms in irritable bowel syndrome.
    Cremonini F; Talley NJ
    Nat Clin Pract Gastroenterol Hepatol; 2005 Feb; 2(2):82-8. PubMed ID: 16265125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychotherapy in somatic diseases--for example gastrointestinal disorders].
    Moser G
    Psychiatr Danub; 2007 Dec; 19(4):327-31. PubMed ID: 18000484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mixture of Escherichia coli (DSM 17252) and Enterococcus faecalis (DSM 16440) for treatment of the irritable bowel syndrome--a randomized controlled trial with primary care physicians.
    Enck P; Zimmermann K; Menke G; Müller-Lissner S; Martens U; Klosterhalfen S
    Neurogastroenterol Motil; 2008 Oct; 20(10):1103-9. PubMed ID: 18565142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.